3BOISSIER M C, SEMERANO L, CHALLAL S, et al. Rheumatoid arthritis: From autoimmunity to synovitis and joint destruction [J]. JAutoimmun, 2012, 39(3): 222 -228.
4ALETAHA D, NEOGI T, SILMAN A J, et al. The 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative[J]. Ann Rheum Dis, 2010, 69(9) : 1580 -1588.
5KOCHI Y, SUZUKI A, YAMADA R, et al. Genetica of Rheumatoid Arthritis : underlying evidence of enthnic differences[J]. J Autoimmun, 2009, 32(3/4) : 158 - 162.
6RAZA K, BUCKLEY C E, SALMON M, et al. Treating very early rheumatoid arthritis[J]. Best Pract Res Clin Rheumatol, 2006, 20(5) : 849 -863.
7VAN VENROOIJ W J, VAN BEERS J J, PRUIJN G J. Anti - CCP antibodies: the past, the present and the future[ J]. Nat Rev Rheumato, 2011, 7 (7) : 391 - 398.
8JULIA A, MARSAL S. The genetic architecture of rheumatoid arthritis: from susceptibility to clinical subphenotype associations [J]. CurrTop Med Chem, 2013, 13(6): 720-731.
9ESALATMANESH K, JAMALI R, JAMALI A, et al. Serum anti - cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis[ J ]. Rheumatol Int, 2012, 32 (12) : 3799 - 3805.
10DEBAUGNIES F, SERVAIS G, BADOT V, et al. Anti - cyclic eitrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis [ J]. Scand J Rheumatol, 2013,42(2) : 108 -114.
